{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T13:56:29Z","timestamp":1648907789403},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1995,10,1]],"date-time":"1995-10-01T00:00:00Z","timestamp":812505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[1995,10]]},"DOI":"10.1097\/00000441-199510000-00007","type":"journal-article","created":{"date-parts":[[2006,10,2]],"date-time":"2006-10-02T09:50:50Z","timestamp":1159782650000},"page":"161-166","source":"Crossref","is-referenced-by-count":2,"title":["Case Report: Analgesic Nephropathy: A Soda and a Powder"],"prefix":"10.1016","volume":"310","author":[{"given":"Richard G.","family":"Appel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Bleyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/00000441-199510000-00007_bb0655","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1056\/NEJM198905113201908","article-title":"Analgesic nephropathy\u2014A preventable renal disease","volume":"320","author":"Bennett","year":"1989","journal-title":"N Engl J Med."},{"key":"10.1097\/00000441-199510000-00007_bb0660","first-page":"1","article-title":"Die chronische interstitielle nephritis","volume":"151","author":"Spuhler","year":"1953","journal-title":"Zeitschrift fur Klinische Medizin."},{"key":"10.1097\/00000441-199510000-00007_bb0665","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0272-6386(86)80139-1","article-title":"Analgesic-associated nephropathy: An important cause of chronic renal failure in the United States?","volume":"7","author":"Goldberg","year":"1986","journal-title":"Am J Kidney Dis."},{"key":"10.1097\/00000441-199510000-00007_bb0670","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00005792-198609000-00002","article-title":"Renal disease from habitual antipyretic analgesic consumption: An assessment of the epidemiologic evidence","volume":"11","author":"Buckalew","year":"1986","journal-title":"Medicine."},{"key":"10.1097\/00000441-199510000-00007_bb0675","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM198302173080703","article-title":"Epidemiologic study of abuse of analgesics containing phenacetin","volume":"308","author":"Dubach","year":"1983","journal-title":"N Engl J Med."},{"key":"10.1097\/00000441-199510000-00007_bb0680","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJM199101173240304","article-title":"An epidemiologic study of abuse of analgesic drugs. Effects of phenacetin and salicylate on mortality and cardiovascular mortality (1968 to 1987)","volume":"324","author":"Dubach","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1097\/00000441-199510000-00007_bb0685","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1056\/NEJM199101173240310","article-title":"The risks of phenacetin use","volume":"324","author":"Stolley","year":"1991","journal-title":"N Engl J Med."},{"key":"10.1097\/00000441-199510000-00007_bb0690","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/archinte.1983.00350090053009","article-title":"Epidemiologic study of regular analgesic use and end-stage renal disease","volume":"143","author":"Murray","year":"1983","journal-title":"Arch Intern Med."},{"key":"10.1097\/00000441-199510000-00007_bb0695","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJM198905113201903","article-title":"Analgesic use and chronic renal disease","volume":"320","author":"Sandler","year":"1989","journal-title":"N Engl J Med."},{"key":"10.1097\/00000441-199510000-00007_bb0700","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000185116","article-title":"Paracetamol: A cause for analgesic nephropathy and end-stage renal disease","volume":"50","author":"Segasothy","year":"1988","journal-title":"Nephron."},{"key":"10.1097\/00000441-199510000-00007_bb0705","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0272-6386(12)80155-7","article-title":"Chronic renal disease and papillary necrosis associated with the long-term use of non-steroidal antiinflammatory drugs as the sole or predominant analgesic","volume":"24","author":"Segasothy","year":"1994","journal-title":"Am J Kidney Dis."},{"key":"10.1097\/00000441-199510000-00007_bb0710","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-115-3-165","article-title":"Nonsteroidal antiinflammatory drugs and the risk for chronic renal disease","volume":"115","author":"Sandler","year":"1991","journal-title":"Ann Intern Med."},{"key":"10.1097\/00000441-199510000-00007_bb0715","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJM199412223312502","article-title":"Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs","volume":"331","author":"Perneger","year":"1994","journal-title":"N Engl J Med."},{"key":"10.1097\/00000441-199510000-00007_bb0720","series-title":"Primer on Kidney Disease","first-page":"192","article-title":"Analgesic abuse nephropathy","author":"Buckalew","year":"1994"},{"key":"10.1097\/00000441-199510000-00007_bb0725","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2125.1990.tb03841.x","article-title":"End-stage renal disease and non-narcotic analgesics: A case-control study","volume":"30","author":"Morlans","year":"1990","journal-title":"Br J Clin Pharmacol."},{"key":"10.1097\/00000441-199510000-00007_bb0730","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000168002","article-title":"Regular analgesic intake and the risk of end-stage renal failure","volume":"9","author":"Pommer","year":"1989","journal-title":"Am J Nephrol."},{"key":"10.1097\/00000441-199510000-00007_bb0735","first-page":"479","article-title":"Diagnostic criteria of analgesic nephropathy in patients with end stage renal failure: Results of the Belgian study","volume":"7","author":"Elseviers","year":"1992","journal-title":"Nephrol Dial Transplant."},{"key":"10.1097\/00000441-199510000-00007_bb0740","series-title":"Emmett\u2019s Clinical Urography","first-page":"1928","article-title":"Renal failure and renal parenchymal disease","author":"Hattery","year":"1977"},{"key":"10.1097\/00000441-199510000-00007_bb0745","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-93-2-249","article-title":"Analgesic-associated nephropathy and transitional cell carcinoma of the urinary tract","volume":"93","author":"Gonwa","year":"1980","journal-title":"Ann Intern Med."},{"key":"10.1097\/00000441-199510000-00007_bb0750","first-page":"35","article-title":"The effect of withdrawal of phenacetin-containing analgesics on the incidence of kidney and urothelial cancer and renal failure","volume":"31","author":"McCredie","year":"1989","journal-title":"Clin Nephrol."},{"key":"10.1097\/00000441-199510000-00007_bb0755","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM198508013130504","article-title":"Heavy phenacetin use and bladder cancer in women aged 20 to 49years","volume":"313","author":"Piper","year":"1985","journal-title":"N Engl J Med."},{"key":"10.1097\/00000441-199510000-00007_bb0760","first-page":"161","article-title":"Acetaminophen nephrotoxicity: Studies on renal acetylation and deacetylation","volume":"218","author":"Carpenter","year":"1981","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1097\/00000441-199510000-00007_bb0765","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0272-6386(86)80141-X","article-title":"Renal failure in America is infrequently due to analgesic abuse","volume":"7","author":"Maher","year":"1986","journal-title":"Am J Kidney Dis."},{"key":"10.1097\/00000441-199510000-00007_bb0770","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/path.1711640409","article-title":"Irreversible damage to the medullary interstitium in experimental analgesic nephropathy in F344 rats","volume":"164","author":"Burrell","year":"1991","journal-title":"J Pathol."},{"key":"10.1097\/00000441-199510000-00007_bb0775","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/ndt\/9.10.1371","article-title":"End-stage renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality","volume":"9","author":"Brunner","year":"1994","journal-title":"Nephrol Dial Transplant."},{"key":"10.1097\/00000441-199510000-00007_bb0780","first-page":"1377","article-title":"Trends in incidence of end-stage renal failure in Australia, 1972\u20131991","volume":"9","author":"Stewart","year":"1994","journal-title":"Nephrol Dial Transplant."},{"key":"10.1097\/00000441-199510000-00007_bb0785","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0272-6386(95)90641-X","article-title":"Demography and survival of patients receiving treatment for chronic renal failure in Australia and New Zealand: Report on dialysis and renal transplantation treatment from the Australia and New Zealand dialysis and transplant registry","volume":"25","author":"Disney","year":"1995","journal-title":"Am J Kidney Dis."},{"key":"10.1097\/00000441-199510000-00007_bb0790","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0272-6386(86)80140-8","article-title":"Analgesic nephropathy: A significant cause of morbidity in the United States","volume":"7","author":"Buckalew","year":"1986","journal-title":"Am J Kidney Dis."},{"key":"10.1097\/00000441-199510000-00007_bb0795","first-page":"S48","article-title":"1994 annual data report: Incidence and causes of treated ESRD","volume":"24","author":"USRDS","year":"1994","journal-title":"Am J Kidney Dis."},{"key":"10.1097\/00000441-199510000-00007_bb0800","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1056\/NEJM198403013100905","article-title":"Renal syndromes associated with nonsteroidal antiinflammatory drugs","volume":"310","author":"Clive","year":"1984","journal-title":"N Engl J Med."},{"key":"10.1097\/00000441-199510000-00007_bb0805","first-page":"65","article-title":"Analgesic nephrotoxicity and renal papillary necrosis","volume":"4","author":"Eknoyan","year":"1984","journal-title":"Semin Nephrol."},{"key":"10.1097\/00000441-199510000-00007_bb0810","first-page":"41","article-title":"Analgesic-induced papillary necrosis","volume":"8","author":"Sabatini","year":"1988","journal-title":"Semin Nephrol."},{"key":"10.1097\/00000441-199510000-00007_bb0815","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev.pa.28.040188.001555","article-title":"Drug nephrotoxicity","volume":"28","author":"Walker","year":"1988","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"10.1097\/00000441-199510000-00007_bb0820","first-page":"F169","article-title":"Prostaglandins and the kidney","volume":"233","author":"Dunn","year":"1977","journal-title":"Am J Physiol."},{"key":"10.1097\/00000441-199510000-00007_bb0825","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0272-6386(89)80062-9","article-title":"The pathophysiological implications of medullary hypoxia","volume":"13","author":"Brezis","year":"1989","journal-title":"Am J Kidney Dis."},{"key":"10.1097\/00000441-199510000-00007_bb0830","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJM199503093321006","article-title":"Hypoxia of the renal medulla\u2014Its implications for disease","volume":"332","author":"Brezis","year":"1995","journal-title":"N Engl J Med."},{"key":"10.1097\/00000441-199510000-00007_bb0835","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000168125","article-title":"Caffeine potentiates the nephrotoxicity of mefenamic acid on the rat renal papilla","volume":"10","author":"Champion de Crespigny","year":"1990","journal-title":"Am J Nephrol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915350126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962915350126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T11:45:03Z","timestamp":1555847103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962915350126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,10]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,10]]}},"alternative-id":["S0002962915350126"],"URL":"https:\/\/doi.org\/10.1097\/00000441-199510000-00007","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[1995,10]]}}}